Serum Cholesterol Levels and Risk of Cardiovascular Death: A Systematic Review and a Dose-Response Meta-Analysis of Prospective Cohort Studies
The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Introduction: Numerous studies have demonstrated that abnormal levels of cholesterol are associated with a high attributable risk for the occurrence of cardiovascular disease (CVD). However, there has been no comprehensive study to investigate the relationship between serum cholesterol levels and cardiovascular mortality. Therefore, we conducted a systematic review and dose-response meta-analysis. Methods: A systematic literature search of key databases, including EMBASE and MEDLINE, was conducted and included all the published epidemiological studies that contained estimates of the hazard ratios (HR) of serum cholesterol of CVD mortality. Data extraction, eligibility, and assessment of the risk of bias were assessed by two reviewers independently. All published risk estimates were hazard ratios and analyzed by quantitative meta-analysis using a random-effects model and dose-response relationships of serum cholesterol with CVD mortality. Results: A total of 14 independent reports, including 1,055,309 subjects and 9457 events, were analyzed. The pooled HR (95% CI) was 1.27 (95% CI, 1.19–1.36) for total cholesterol, 1.21 (95% CI, 1.09–1.35) for low-density lipoprotein cholesterol (LDL-C), and 0.60 (95% CI, 0.50–0.72) for high-density lipoprotein cholesterol (HDL-C). We observed a linear association between serum cholesterol (TC, HDL-C) levels and CVD mortality in this meta-analysis. Conclusions: Serum total cholesterol and LDL-C level is associated with increased CVD mortality, but HDL-C level is inversely associated with CVD mortality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Higgins, J. P. T., Altman, D. G., Gotzsche, P. C., Juni, P., Moher, D., Oxman, A. D., Savovic, J., Schulz, K. F., Weeks, L., Sterne, J. A. C., et al. (2011) · BMJ · doi:10.1136/bmj.d5928 · Cited by 33,817
Stang, A. (2010) · European Journal of Epidemiology · doi:10.1007/s10654-010-9491-z · Cited by 17,396
Yusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17018-9 · Cited by 12,026
Prediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581 · cited 1×
“the main risk factor for CVD by many epidemiological and interventional studies because LDL-C plays a major role in the pathogenesis of atherosclerosis [7,8].”
BackgroundHigh density lipoprotein as a protective factor against coronary heart disease
Gordon, T., Castelli, W. P., Hjortland, M. C., Kannel, W. B., & Dawber, T. R. (1977) · The American Journal of Medicine · doi:10.1016/0002-9343(77)90874-9 · Cited by 5,059
Interpretation of random effects meta-analyses
Riley, R. D., Higgins, J. P. T., & Deeks, J. J. (2011) · BMJ · doi:10.1136/bmj.d549 · Cited by 2,884 · cited 1×
“However, we noted that overall statistical heterogeneity for each meta-analysis, as measured by the I2 statistic, was moderate, and we chose a random-effect model to account for differences in effect size between each study [53].”
MethodMethods for Trend Estimation from Summarized Dose-Response Data, with Applications to Meta-Analysis
Greenland, S., & Longnecker, M. P. (1992) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116237 · Cited by 2,353 · cited 2×
“If the upper and lower limits of the category were not provided, both limits were assumed to have the same amplitude as the closet category (the lowest boundary was assumed to be zero, the highest boundary had the same amplitude as the preceding category) [13,14].”
BackgroundMethodStewart, L. A., Clarke, M., Rovers, M., Riley, R. D., Simmonds, M., Stewart, G., & Tierney, J. F. (2015) · JAMA · doi:10.1001/jama.2015.3656 · Cited by 2,134
Sackett, D. L. (1979) · Journal of Chronic Diseases · doi:10.1016/0021-9681(79)90012-2 · Cited by 2,075
Statins for the primary prevention of cardiovascular disease
Taylor, F., Huffman, M. D., Macedo, A. F., Moore, T. H., Burke, M., Davey Smith, G., Ward, K., Ebrahim, S., & Gay, H. C. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004816.pub5 · Cited by 1,934
A Century of Cholesterol and Coronaries: From Plaques to Genes to Statins
Goldstein, J. L., & Brown, M. S. (2015) · Cell · doi:10.1016/j.cell.2015.01.036 · Cited by 1,233 · cited 1×
“However, there is an absence of a meta-analysis on CVD mortality and serum levels of cholesterol, which is routinely referred to as a causal factor in producing CVD and is a target of medical treatment of CVD [35].”
BackgroundBrugts, J. J., Yetgin, T., Hoeks, S. E., Gotto, A. M., Shepherd, J., Westendorp, R. G. J., de Craen, A. J. M., Knopp, R. H., Nakamura, H., Ridker, P., et al. (2009) · BMJ · doi:10.1136/bmj.b2376 · Cited by 792 · cited 1×
“In studies of the relationship between cholesterol and CVD occurrence, treatment with TC or LDL-C lowering drugs reduces CVD mortality [44,45].”
BackgroundShahar, E., Chambless, L. E., Rosamond, W. D., Boland, L. L., Ballantyne, C. M., McGovern, P. G., & Sharrett, A. R. (2003) · Stroke · doi:10.1161/01.str.0000057812.51734.ff · Cited by 325
How to read a funnel plot in a meta-analysis
Sedgwick, P., & Marston, L. (2015) · BMJ · doi:10.1136/bmj.h4718 · Cited by 318
Leppälä, J. M., Virtamo, J., Fogelholm, R., Albanes, D., & Heinonen, O. P. (1999) · Stroke · doi:10.1161/01.str.30.12.2535 · Cited by 272 · cited 2×
“The Multiple Risk Factor Intervention Trial (MRFIT) found an association between high serum TC levels and the incidence of ischemic stroke [37].”
MethodHigh-density lipoprotein cholesterol, coronary artery disease, and cardiovascular mortality
Silbernagel, G., Schottker, B., Appelbaum, S., Scharnagl, H., Kleber, M. E., Grammer, T. B., Ritsch, A., Mons, U., Holleczek, B., Goliasch, G., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht343 · Cited by 123 · cited 3×
“With the exception of 3 studies [22,27,29], 11 studies had a follow-up duration of more than 10 years [20,21,23–26,28,30–33] (Table 1).”
BackgroundInfluentialKunutsor, S. K., Zaccardi, F., Karppi, J., Kurl, S., & Laukkanen, J. A. (2017) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.37184 · Cited by 109
Electron beam tomography and National Cholesterol Education Program guidelines in asymptomatic women
Hecht, H. S., & Superko, H. R. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01211-6 · Cited by 88 · cited 1×
“However, according to a compr hensive eview of the association of LDL-C with atherosclerosis, some studies have shown a lack of an association between LDL-C and severity of atherosclerosis, and in a study of 304 women, there was no association between LDL-C and coronary calcification [41,42].”
Satoh, M., Ohkubo, T., Asayama, K., Murakami, Y., Sakurai, M., Nakagawa, H., Iso, H., Okayama, A., Miura, K., Imai, Y., et al. (2015) · Hypertension · doi:10.1161/hypertensionaha.114.04639 · Cited by 54 · cited 4×
“The main results of the analysis were CVD mortality, and the study used it when CHD mortality was presented as a study outcome [23,28].”
BackgroundMethodResultInfluentialHarari, G., Green, M. S., Magid, A., & Zelber-Sagi, S. (2017) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2017.01.008 · Cited by 49 · cited 6×
“Four studies compared the highest level with the lowest (or referent) level categories of LDL-C [26,27,30,33].”
BackgroundMethodInfluential
Research works printed but not linked: 31
- Fuster, V., and Kelly, B.B. (2010). The National Academies Collection: Reports funded by National Institutes of Health. Promoting Cardiovascular Health in the Developing World: A Critical Challenge to Achieve Global Health, National Academies Press (US).
- Casula, M., Colpani, O., Xie, S., Alberico, L., and Baragetti, A. (2021). HDL in Atherosclerotic Cardiovascular Disease: In Search of a Role. Cells, 10. · DOI
- Stamler, 2000, Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular, and all-cause mortality and to longevity, JAMA, 284, 311, 10.1001/jama.284.3.311 · DOI · Paper page
- Gofman, 1954, Lipoproteins, coronary heart disease, and atherosclerosis, Physiol. Rev., 34, 589, 10.1152/physrev.1954.34.3.589 · DOI · Paper page
- Steinberg, 2009, The LDL modification hypothesis of atherogenesis: An update, J. Lipid Res., 50, S376, 10.1194/jlr.R800087-JLR200 · DOI · Paper page
- Knobloch, 2011, Preferred reporting items for systematic reviews and meta-analyses (PRISMA) statement and publication bias, J. Craniomaxillofacial Surg., 39, 91, 10.1016/j.jcms.2010.11.001 · DOI · Paper page
- Orsini, 2006, Generalized least squares for trend estimation of summarized dose-response data, Stata J., 6, 40, 10.1177/1536867X0600600103 · DOI · Paper page
- Higgins, 2002, Quantifying heterogeneity in a meta-analysis, Stat. Med., 21, 1539, 10.1002/sim.1186 · DOI · Paper page
- Higgins, 2003, Measuring inconsistency in meta-analyses, BMJ, 327, 557, 10.1136/bmj.327.7414.557 · DOI · Paper page
- DerSimonian, 1986, Meta-analysis in clinical trials, Control Clin. Trials, 7, 177, 10.1016/0197-2456(86)90046-2 · DOI · Paper page
- Hirata, 2016, The Relationship between Very High Levels of Serum High-Density Lipoprotein Cholesterol and Cause-Specific Mortality in a 20-Year Follow-Up Study of Japanese General Population, J. Atheroscler. Thromb., 23, 800, 10.5551/jat.33449 · DOI · Paper page
- Hirata, 2018, Association of extremely high levels of high-density lipoprotein cholesterol with cardiovascular mortality in a pooled analysis of 9 cohort studies including 43,407 individuals: The EPOCH-JAPAN study, J. Clin. Lipidol., 12, 674, 10.1016/j.jacl.2018.01.014 · DOI · Paper page
- Okamura, 2006, The inverse relationship between serum high-density lipoprotein cholesterol level and all-cause mortality in a 9.6-year follow-up study in the Japanese general population, Atherosclerosis, 184, 143, 10.1016/j.atherosclerosis.2005.03.042 · DOI
- Kilander, 2001, Education, lifestyle factors and mortality from cardiovascular disease and cancer. A 25-year follow-up of Swedish 50-year-old men, Int. J. Epidemiol., 30, 1119, 10.1093/ije/30.5.1119 · DOI · Paper page
- Johan, 2006, Clinical value of the metabolic syndrome for long term prediction of total and cardiovascular mortality: Prospective, population based cohort study, BMJ, 332, 878, 10.1136/bmj.38766.624097.1F · DOI · Paper page
- Oksala, 2013, Complementary prediction of cardiovascular events by estimated apo- and lipoprotein concentrations in the working age population. The Health 2000 Study, Ann. Med., 45, 141, 10.3109/07853890.2012.679962 · DOI
- Holme, 2011, Association of coronary heart disease mortality with risk factors according to length of follow-up and serum cholesterol level in men: The Oslo Study cohort, Eur. J. Prev. Cardiol., 20, 168, 10.1177/1741826711432514 · DOI
- Tikhonoff, 2005, Low-density lipoprotein cholesterol and mortality in older people, J. Am. Geriatr. Soc., 53, 2159, 10.1111/j.1532-5415.2005.00492.x · DOI · Paper page
- Hu, 2017, A novel cardiovascular death prediction model for Chinese individuals: A prospective cohort study of 381,963 study participants, Atherosclerosis, 264, 19, 10.1016/j.atherosclerosis.2017.07.016 · DOI
- Thorgeirsson, 2005, Risk factors for out-of-hospital cardiac arrest: The Reykjavik Study, Eur. Heart J., 26, 1499, 10.1093/eurheartj/ehi179 · DOI
- Ravnskov, 2003, High cholesterol may protect against infections and atherosclerosis, QJM, 96, 927, 10.1093/qjmed/hcg150 · DOI
- Ulmer, 2004, Why Eve is not Adam: Prospective follow-up in 149650 women and men of cholesterol and other risk factors related to cardiovascular and all-cause mortality, J. Women’s Health, 13, 41, 10.1089/154099904322836447 · DOI
- Ravnskov, 2002, Is atherosclerosis caused by high cholesterol?, QJM, 95, 397, 10.1093/qjmed/95.6.397 · DOI
- Ray, 2014, The ACC/AHA 2013 guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: The good the bad and the uncertain: A comparison with ESC/EAS guidelines for the management of dyslipidaemias 2011, Eur. Heart J., 35, 960, 10.1093/eurheartj/ehu107 · DOI · Paper page
- Pignone, 2000, Use of lipid lowering drugs for primary prevention of coronary heart disease: Meta-analysis of randomised trials, BMJ, 321, 983, 10.1136/bmj.321.7267.983 · DOI · Paper page
- Kannel, 1964, Risk factors in coronary heart disease: An evaluation of several serum lipids as predictors of coronary heart disease: The framingham study, Ann. Intern. Med., 61, 888, 10.7326/0003-4819-61-5-888 · DOI · Paper page
- Gao, 2012, Lipid-related markers and cardiovascular disease prediction, JAMA, 307, 2499
- Lu, 2013, Low HDL-C predicts risk and PCI outcomes in the Han Chinese population, Atherosclerosis, 226, 193, 10.1016/j.atherosclerosis.2012.09.011 · DOI
- Rubin, 1991, Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI, Nature, 353, 265, 10.1038/353265a0 · DOI · Paper page
- Tangirala, 1999, Regression of atherosclerosis induced by liver-directed gene transfer of apolipoprotein A-I in mice, Circulation, 100, 1816, 10.1161/01.CIR.100.17.1816 · DOI · Paper page
- Egger, 1997, Bias in meta-analysis detected by a simple, graphical test, BMJ, 315, 629, 10.1136/bmj.315.7109.629 · DOI · Paper page
Metadata
- Authors
- Jung, E., Kong, S. Y., Ro, Y. S., Ryu, H. H., & Shin, S. D.
- Venue
- International Journal of Environmental Research and Public Health
- Publisher
- MDPI AG
- Published
- 2022-07-06
- Volume
- 19
- Issue
- 14
- Pages
- 8272
- ISSN
- 1660-4601
- Cited by
- 211
- References
- 22
- Language
- en
- Funders
- Chonnam National University Hospital (BCRI-19018)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.